The Relative Clinical and Economic Value of Ipilimumab as First-Line Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases
May 1, 2014, 00:00
10.1016/j.jval.2014.03.410
https://www.valueinhealthjournal.com/article/S1098-3015(14)00461-6/fulltext
Title :
The Relative Clinical and Economic Value of Ipilimumab as First-Line Treatment of Metastatic Melanoma Versus Other Anti-Cancer Agents for Metastatic Diseases
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00461-6&doi=10.1016/j.jval.2014.03.410
First page :
A70
Section Title :
Cancer
Open access? :
No
Section Order :
1457